跳至主要内容
临床试验/IRCT138805012159N2
IRCT138805012159N2已完成2 期

Evaluating the effect of Fluoxetine on symptoms and quality of life of patients with moderate to sever irritable bowel syndrome in adults.

Isfahan University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • age 18-65 years, IBS diagnosis through ROME II criteria, moderate to severe symptoms through severity of symptom questionnaire Exclusion criteria : Diagnosis of any organic disease related to symptoms during the study, psychological disorders Taking any other psychotropic drugs at the beginning or during the trial or taking a MAO-inhibitor drugs during 2 weeks before entering to the trial, record of taking Fluoxetine for treatment of IBS in the past, Presence of any contraindications for taking Fluoxetine, low compliance, severe complications due to Fluoxetine, Pregnancy or breastfeeding at the beginning or during the trial

排除标准

  • 未提供

研究者

相似试验